43
In band
Moving averages
SMA 200$8.76-80.48%
Company profile
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies that address unmet medical needs in oncology in the United States. The company is headquartered in Toronto, Canada.
SectorHealthcare
IndustryBiotechnology
Market cap$4.36M
P/E ratioNone
EPS$-36.38
Beta1.134
Dividend yield0.00%
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 52
VRTX
Vertex Pharmaceuticals Inc
RSI 64
CRSP
CRISPR Therapeutics AG
RSI 54
IOVA
Iovance Biotherapeutics Inc
RSI 66
MRNA
Moderna Inc
RSI 67
VKTX
Viking Therapeutics Inc
RSI 49
SRPT
Sarepta Therapeutics Inc
RSI 67
EDIT
Editas Medicine Inc
RSI 52
NVAX
Novavax Inc
RSI 72
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 44
RSI alerts for APTO
Get an email the moment Aptose Biosciences Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 1:39 AM EDT